Company Badge
USPTO Data Jan 1 1976 - Oct 13 2026
11 Patents
#642 in New York, NY
#1,598 in New York
#27,514 in US
#51,761 in the World
Axim Biotechnologies, Inc.
Forward Citations = 31
18 inventors:
New York, NY, United States of America
Axim Biotechnologies, Inc.
% Expired Patents = 9.1
Trademarks = 4
Forward Citations = 31
Loading Chart...
Loading Chart...
18 inventors (with patents filed for the assignee):
Lekhram Changoer (9 out of 16 patents)
George Evgeniyevich Anastassov (7 out of 16 patents)
Cornelis Herman Michel Van Der Loo (2 out of 3 patents)
4. Erik Keller (2 out of 3 patents)
5. Jeffrey LaBelle (1 out of 26 patents)
6. Philippus Anne Van Damme (1 out of 4 patents)
7. Garrett Repp (1 out of 3 patents)
8. Chi Lin (1 out of 3 patents)
9. Mark Spano (1 out of 2 patents)
10. Sergei Svarovsky (1 out of 4 patents)
11. Marcus Smith (1 out of 2 patents)
12. Jennifer Blain Christen (1 out of 6 patents)
13. Hongwu Jiang (1 out of 1 patent)
14. Andrew Penman (1 out of 1 patent)
15. Pierce Youngbar (1 out of 1 patent)
11 patents:
Company Overview
Axim Biotechnologies, Inc. is a biotechnology company based in New York, specializing in the development of innovative therapeutic solutions. The organization focuses on advancing cannabinoid-based products aimed at addressing various medical conditions, leveraging its expertise in pharmaceutical formulations and delivery systems. Axim is committed to research and development in the fields of biopharmaceuticals and natural product extraction, striving to enhance patient outcomes through scientifically validated approaches.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Axim Biotechnologies, Inc.. Retrieved from https://idiyas.com/company/axim-biotechnologies
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]